Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: BostonView who wrote (11374)	8/18/1999 10:18:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 17367

More stuff. Cacaito reminded us of the Giroir-Duncan exchanges regarding the phase I/II paper in the Lancet. Here are some links: thelancet.com thelancet.com thelancet.com thelancet.com And, George, I am not ignoring your and opal's chest link; it takes a while to digest. Here it is again for those interested: chestnet.org If someone finds an example of a company "non-releasing" pivotal phase III data AND then going on successfully to registration, please let the thread now. We have seen already several examples of companies releasing numbers and p-values, without apparent fear of the FDA chewing their heads, or even slapping their hands. Of course, we can say that this is a historical-biological-subpart-E-etc-etc-etc and shut-up-and-buy kind of situation. But I was wishing that maybe, just maybe, we can do better than that -g- PB